Literature DB >> 15707681

Peptide mimics of epidermal growth factor (EGF) with antagonistic activity.

Takashi Nakamura1, Hiroshi Takasugi, Tomoyasu Aizawa, Masanobu Yoshida, Mineyuki Mizuguchi, Yoshihiro Mori, Hiroyuki Shinoda, Yoichi Hayakawa, Keiichi Kawano.   

Abstract

Epidermal growth factor is a potent growth-promoting factor for a variety of tissue cells in vivo and in vitro. Epidermal growth factor binds, phosphorylates, and activates epidermal growth factor receptors on the cell surface. In this study, we attempted to design functional peptide mimics by panning a phage display library on the anti-epidermal growth factor monoclonal antibody. By using anti-epidermal growth factor monoclonal antibody as a mold of the structure of the binding site of epidermal growth factor, high-efficiency probing was expected. From a random peptide phage display library, phage clones that bind to the anti-epidermal growth factor monoclonal antibody were isolated. One of the phage clones also exhibited binding activity to the epidermal growth factor receptor. The amino acid sequence of this phage clone showed slight similarity to the primary sequence of epidermal growth factor. We synthesized this motif to a 9-amino-acid intramolecularly disulfide-linked peptide. This synthetic peptide inhibited mitogenesis as well as epidermal growth factor receptor tyrosine phosphorylation, which is induced by epidermal growth factor. The present results suggest that the peptide synthesized in this study may mimic the epidermal growth factor receptor-binding region in epidermal growth factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15707681     DOI: 10.1016/j.jbiotec.2004.10.021

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  9 in total

Review 1.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity.

Authors:  Berrin Erdag; Koray B Balcioglu; Asli Kumbasar; Omur Celikbicak; Gabrielle Zeder-Lutz; Danièle Altschuh; Bekir Salih; Kemal Baysal
Journal:  Mol Biotechnol       Date:  2007-01       Impact factor: 2.695

3.  Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells.

Authors:  Mikkel Staberg; Christian Riemer; Ruodan Xu; Oksana Dmytriyeva; Elisabeth Bock; Vladimir Berezin
Journal:  Cell Oncol (Dordr)       Date:  2013-04-12       Impact factor: 6.730

4.  Avidity-controlled delivery of angiogenic peptides from injectable molecular-recognition hydrogels.

Authors:  Widya Mulyasasmita; Lei Cai; Yuki Hori; Sarah C Heilshorn
Journal:  Tissue Eng Part A       Date:  2014-02-03       Impact factor: 3.845

5.  Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia.

Authors:  Nitin Nitin; Kelsey J Rosbach; Adel El-Naggar; Michelle Williams; Ann Gillenwater; Rebecca R Richards-Kortum
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

6.  Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging.

Authors:  Honglin Jin; Jonathan F Lovell; Juan Chen; Kenneth Ng; Weiguo Cao; Lili Ding; Zhihong Zhang; Gang Zheng
Journal:  Cancer Nanotechnol       Date:  2010-11-11

7.  IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia.

Authors:  Nianhuan Zhao; Zhiwei Yue; Jian Cui; Yong Yao; Xianghe Song; Bangping Cui; Xin Qi; Zhibo Han; Zhong-Chao Han; Zhikun Guo; Zuo-Xiang He; Zongjin Li
Journal:  Stem Cell Res Ther       Date:  2019-04-29       Impact factor: 6.832

8.  Development of an epidermal growth factor derivative with EGFR blocking activity.

Authors:  Clara Panosa; Francesc Tebar; Montserrat Ferrer-Batallé; Humphrey Fonge; Masaharu Seno; Raymond M Reilly; Anna Massaguer; Rafael De Llorens
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

9.  YAC tripeptide of epidermal growth factor promotes the proliferation of HaCaT keratinocytes through activation of EGFR.

Authors:  Yeon Ho Yoo; Yu Ri Kim; Min Seo Kim; Kyoung-Jin Lee; Kyeong Han Park; Jang-Hee Hahn
Journal:  BMB Rep       Date:  2014-10       Impact factor: 4.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.